Drawing for LARODAN

USPTO serial 79312592

LARODAN

Reviewed by CopyMark Law Group

Reg. 6749347Status 700Registered
Filing date
Status date
Registration date
Jun 7, 2022
Examiner
BLANE, SUZANNE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LARODAN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William C. Wright

William C. Wright Epstein Drangel LLP60 East 42nd Street, Suite 1250New York, NY 10165United States

Goods and services

ClassDescriptionStatusFirst use
001Chemical compounds for scientific or research use in the field of pharmaceuticals, cosmetics, biofuels, veterinary products, food and nutritional products, and diagnostic products; lipids and lipid-like compounds consisting of chemicals and substrates, for use in industry; lipids and lipid-like compounds consisting of chemicals and substrates, for use as analytical standards and laboratory reagents; lipids and lipid-like compounds consisting of chemicals and substrates, for use in the research, development and quality control of products and processes; lipids and lipid-like compounds consisting of chemicals and substrates, for use in making chemical products used in the fields of pharmaceuticals, cosmetics, biofuels, veterinary products, food and nutritional products, and diagnostic products; lipids and lipid-like compounds consisting of chemicals and substrates, for use in the development and manufacture of chemical products, pharmaceuticals, cosmetics, biofuels, veterinary products, food and nutritional products, and diagnostic products; lipids and lipid-like compounds consisting of chemicals and substrates, for use in pharmacological, biochemical, agrochemical and nutritional studies and in clinical trialsACTIVE—
035Retail and wholesale store services featuring chemical compounds for scientific or research use; retail and wholesale store services featuring lipids and lipid-like compounds consisting of chemicals and substrates, for use in industry; retail and wholesale store services featuring lipids and lipid-like compounds consisting of chemicals and substrates, for use as analytical standards and laboratory reagents; retail and wholesale store services featuring lipids and lipid-like compounds consisting of chemicals and substrates, for use in the research, development and quality control of products and processes; retail and wholesale store services featuring lipids and lipid-like compounds consisting of chemicals and substrates, for use in chemical products, pharmaceuticals, cosmetics, biofuels, veterinary products, food and nutritional products, and diagnostic products; retail and wholesale store services featuring lipids and lipid-like compounds consisting of chemicals and substrates, for use in the development and manufacture of chemical products, pharmaceuticals, cosmetics, biofuels, veterinary products, food and nutritional products, and diagnostic products; retail and wholesale store services featuring lipids and lipid-like compounds consisting of chemicals and substrates, for use in pharmacological, biochemical, agrochemical and nutritional studies and in clinical trials; retail and wholesale store services featuring lipids and lipid-like compounds consisting of chemicals and substrates, for use in pharmaceutical and veterinary products, and in nutritional supplementsACTIVE—
042Chemical analysis services; working on and evaluation of chemical syntheses; working on and evaluation of chemical analyses; chemical analysis of lipids and lipid-like compounds consisting of chemicals and substratesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 26, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 6, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 6, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jan 6, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 6, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 6, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 6, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 10, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 21, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 20, 2022FIMPFINAL DISPOSITION PROCESSED—
Sep 18, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 7, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 7, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 7, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 22, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 22, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 21, 2022GPNXNOTIFICATION PROCESSED BY IB—
Mar 2, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 2, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 2, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 12, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 12, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 11, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 11, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 29, 2021RFNTREFUSAL PROCESSED BY IB—
Aug 12, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 12, 2021RFRRREFUSAL PROCESSED BY MPU—
Aug 1, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 31, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 24, 2021DOCKASSIGNED TO EXAMINER—
Jul 17, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 12, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 8, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 3, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance